The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Nanotechnology approaches for inhalation treatment of lung diseases
Open accessAbstract
Local administration of therapeutics by inhalation for treatment of lung diseases has the ability to deliver drugs, nucleic acids and peptides specifically to the site of their action and therefore enhance the efficacy of the treatment, limit the penetration of nebulized therapeutic agent(s) into the bloodstream and consequently decrease adverse systemic side effects of the treatment. Nanotechnology allows for a further enhancement of the treatment efficiency. The present review analyzes modern therapeutic approaches of inhaled nanoscale-based pharmaceutics for the detection and treatment of various lung diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Terminology for biorelated polymers and applications (IUPAC Recommendations 2012)
Vert, M., Doi, Y., Hellwich, K.-H., Hess, M., Hodge, P., Kubisa, P., Rinaudo, M., & Schué, F. (2012) · Pure and Applied Chemistry · doi:10.1351/pac-rec-10-12-04 · Cited by 1,273
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Self-citationHeteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
The spindle checkpoint, aneuploidy, and cancer
Bharadwaj, R., & Yu, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207374 · Cited by 534
Alton, E., Stern, M., Farley, R., Jaffe, A., Chadwick, S., Phillips, J., Davies, J., Smith, S., Browning, J., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 435
Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.
Momparler, R. L., Karon, M. R., Siegel, S. E., & Avila, F. (1976) · PubMed · Cited by 423
Taratula, O., Kuzmov, A., Shah, M., Garbuzenko, O. B., & Minko, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.018 · Cited by 416
Self-citationMoss, R. B., Rodman, D., Spencer, L. T., Aitken, M. L., Zeitlin, P. L., Waltz, D., Milla, C., Brody, A. S., Clancy, J. P., Ramsey, B., et al. (2004) · Chest · doi:10.1378/chest.125.2.509 · Cited by 390
Targeted delivery of magnetic aerosol droplets to the lung
Dames, P., Gleich, B., Flemmer, A., Hajek, K., Seidl, N., Wiekhorst, F., Eberbeck, D., Bittmann, I., Bergemann, C., Weyh, T., et al. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.217 · Cited by 382
Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer
Saad, M., Garbuzenko, O. B., & Minko, T. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.761 · Cited by 367
Self-citationTumor-specific targeting of an anticancer drug delivery system by LHRH peptide
Dharap, S. S., Wang, Y., Chandna, P., Khandare, J. J., Qiu, B., Gunaseelan, S., Sinko, P. J., Stein, S., Farmanfarmaian, A., & Minko, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504274102 · Cited by 340
Self-citationTaratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.019 · Cited by 328
Self-citationRuge, C. A., Kirch, J., & Lehr, C.-M. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70072-9 · Cited by 280
Moss, R. B., Milla, C., Colombo, J., Accurso, F., Zeitlin, P. L., Clancy, J. P., Spencer, L. T., Pilewski, J., Waltz, D. A., Dorkin, H. L., et al. (2007) · Human Gene Therapy · doi:10.1089/hum.2007.022 · Cited by 277
Magnetic core-shell nanoparticles for drug delivery by nebulization
Verma, N. K., Crosbie-Staunton, K., Satti, A., Gallagher, S., Ryan, K. B., Doody, T., McAtamney, C., MacLoughlin, R., Galvin, P., Burke, C. S., et al. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-1 · Cited by 260
Taratula, O., Garbuzenko, O. B., Chen, A. M., & Minko, T. (2011) · Journal of Drug Targeting · doi:10.3109/1061186x.2011.622404 · Cited by 245
Self-citationSaad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
Self-citationRepeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
Hyde, S., Southern, K., Gileadi, U., Fitzjohn, E., Mofford, K., Waddell, B., Gooi, H., Goddard, C., Hannavy, K., Smyth, S., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301212 · Cited by 231
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
Self-citationPatil, M. L., Zhang, M., Taratula, O., Garbuzenko, O. B., He, H., & Minko, T. (2009) · Biomacromolecules · doi:10.1021/bm8009973 · Cited by 213
Self-citationSurface-Modified and Internally Cationic Polyamidoamine Dendrimers for Efficient siRNA Delivery
Patil, M. L., Zhang, M., Betigeri, S., Taratula, O., He, H., & Minko, T. (2008) · Bioconjugate Chemistry · doi:10.1021/bc8000722 · Cited by 213
Self-citationPatil, M. L., Zhang, M., & Minko, T. (2011) · ACS Nano · doi:10.1021/nn102711d · Cited by 210
Self-citationLiposomal doxorubicin (Doxil): An effective new treatment for Kaposi's sarcoma in AIDS
James, N. D., Coker, R. J., Tomlinson, D., Harris, J. R. W., Gompels, M., Pinching, A. J., & Stewart, J. S. W. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80269-9 · Cited by 205
Biological Effects of 5-Azacytidine in Eukaryotes
Čihák, A. (1974) · Oncology · doi:10.1159/000224981 · Cited by 201
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
Kaminskas, L. M., McLeod, V. M., Ryan, G. M., Kelly, B. D., Haynes, J. M., Williamson, M., Thienthong, N., Owen, D. J., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.012 · Cited by 190
Ruiz, F. E., Clancy, J. P., Perricone, M. A., Bebok, Z., Hong, J. S., Cheng, S. H., Meeker, D. P., Young, K. R., Schoumacher, R. A., Weatherly, M. R., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750148667 · Cited by 185
Garbuzenko, O. B., Saad, M., Pozharov, V. P., Reuhl, K. R., Mainelis, G., & Minko, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004604107 · Cited by 185
Self-citationVerschraegen, C. F., Gilbert, B. E., Loyer, E., Huaringa, A., Walsh, G., Newman, R. A., & Knight, V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0929-3 · Cited by 183
Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model
Roa, W. H., Azarmi, S., Al-Hallak, M. H. D. K., Finlay, W. H., Magliocco, A. M., & Löbenberg, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.035 · Cited by 181
Wang, Y., Kho, K., Cheow, W. S., & Hadinoto, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.045 · Cited by 176
Molecular Targeting of Drug Delivery Systems to Cancer
Minko, T., Dharap, S., Pakunlu, R., & Wang, Y. (2004) · Current Drug Targets · doi:10.2174/1389450043345443 · Cited by 175
Self-citationBrito, D. A., Yang, Z., & Rieder, C. L. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200805072 · Cited by 174
Shah, V., Taratula, O., Garbuzenko, O. B., Taratula, O. R., Rodriguez-Rodriguez, L., & Minko, T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1536 · Cited by 173
Self-citationMolecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Nanotechnology approaches for personalized treatment of multidrug resistant cancers
Minko, T., Rodríguez-Rodríguez, L., & Pozharov, V. P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.017 · Cited by 169
Self-citationGarbuzenko, O. B., Saad, M., Betigeri, S., Zhang, M., Vetcher, A. A., Soldatenkov, V. A., Reimer, D. C., Pozharov, V. P., & Minko, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9755-4 · Cited by 167
Self-citationPhase I Study of Aerosolized SLIT Cisplatin in the Treatment of Patients with Carcinoma of the Lung
Wittgen, B. P. H., Kunst, P. W. A., van der Born, K., van Wijk, A. W., Perkins, W., Pilkiewicz, F. G., Perez-Soler, R., Nicholson, S., Peters, G. J., & Postmus, P. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1480 · Cited by 166
Image guided therapy: The advent of theranostic agents
Terreno, E., Uggeri, F., & Aime, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.028 · Cited by 153
Taratula, O., Garbuzenko, O. B., Savla, R., et al. (2010) · Current Drug Delivery · doi:10.2174/156720111793663642 · Cited by 151
Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery
Willis, L., Hayes, D., & Mansour, H. M. (2012) · Lung · doi:10.1007/s00408-011-9360-x · Cited by 148
Pakunlu, R. I., Wang, Y., Tsao, W., Pozharov, V. P., Cook, T. J., & Minko, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0001 · Cited by 148
Self-citationAlipour, S., Montaseri, H., & Tafaghodi, M. (2010) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2010.07.050 · Cited by 144
Gagnadoux, F., Hureaux, J., Vecellio, L., Urban, T., Pape, A. L., Valo, I., Montharu, J., Leblond, V., Boisdron‐Celle, M., Lerondel, S., et al. (2008) · Journal of Aerosol Medicine · doi:10.1089/jamp.2007.0656 · Cited by 144
Etzerodt, A., Maniecki, M. B., Graversen, J. H., Møller, H. J., Torchilin, V. P., & Moestrup, S. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.034 · Cited by 137
Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs
Otterson, G. A., Villalona-Calero, M. A., Sharma, S., Kris, M. G., Imondi, A. R., Gerber, M. C., White, D. A., Ratain, M. J., Schiller, J. H., Sandler, A. B., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1096 · Cited by 136
Pakunlu, R. I., Wang, Y., Saad, M., Khandare, J. J., Starovoytov, V., & Minko, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.010 · Cited by 134
Self-citationDufort, S., Bianchi, A., Henry, M., Lux, F., Duc, G. L., Josserand, V., Louis, C., Perriat, P., Crémillieux, Y., Tillement, O., et al. (2014) · Small · doi:10.1002/smll.201401284 · Cited by 124
Protein stability in pulmonary drug delivery via nebulization
Hertel, S., Winter, G., & Frieß, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.003 · Cited by 123
Garbuzenko, O. B., Mainelis, G., Taratula, O., & Minko, T. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.004 · Cited by 121
Self-citationAnderson, P. M., Markovic, S. N., Sloan, J. A., Clawson, M. L., Wylam, M. E., Arndt, C. A. S., Smithson, W. A., Burch, P. A., Gornet, M. E., & Rahman, E. (1999) · PubMed · Cited by 118
Meenach, S. A., Anderson, K. W., Hilt, J. Z., McGarry, R. C., & Mansour, H. M. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.012 · Cited by 115
Otterson, G. A., Villalona-Calero, M. A., Hicks, W. J., Pan, X. J., Ellerton, J. A., Gettinger, S. N., & Murren, J. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3015 · Cited by 112
Cystic Fibrosis Gene Therapy in the UK and Elsewhere
Uta Griesenbach, D., Pytel, K. M., & Alton, E. W. F. W. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.027 · Cited by 102
Garbuzenko, O. B., Winkler, J. S., Tomassone, M. S., et al. (2014) · Langmuir · doi:10.1021/la502144z · Cited by 101
Synthesis of Starlike N-(2-Hydroxypropyl)methacrylamide Copolymers: Potential Drug Carriers
Wang, D., Kopečková, P., Minko, T., Nanayakkara, V., & Kopec̆ek, J. (2000) · Biomacromolecules · doi:10.1021/bm0000236 · Cited by 100
Self-citationNew Generation of Liposomal Drugs for Cancer
Minko, T., Pakunlu, R. I., Wang, Y., Khandare, J. J., & Saad, M. (2006) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152006778699095 · Cited by 99
Self-citationFeasibility and effectiveness of inhaled carboplatin in NSCLC patients
Zarogoulidis, P., Eleftheriadou, E., Sapardanis, I., Zarogoulidou, V., Lithoxopoulou, H., Kontakiotis, T., Karamanos, N. K., Zachariadis, G. A., Mabroudi, M., Zisimopoulos, A., et al. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9714-5 · Cited by 96
Immunoliposomes and PEGylated Immunoliposomes: Possible Use for Targeted Delivery of Imaging Agents
Torchilin, V. P. (1994) · ImmunoMethods · doi:10.1006/immu.1994.1027 · Cited by 89
Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer
Pitard, B. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh153 · Cited by 89
Patil, R., Ljubimov, A. V., Gangalum, P. R., Ding, H., Portilla‐Arias, J., Wagner, S. R., Inoue, S., Konda, B. M., Rekechenetskiy, A., Chesnokova, A., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b01872 · Cited by 88
Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2
Ivanova, V., Garbuzenko, O. B., Reuhl, K. R., Reimer, D. C., Pozharov, V. P., & Minko, T. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.023 · Cited by 88
Self-citationAdvances in Device and Formulation Technologies for Pulmonary Drug Delivery
Chan, J. G. Y., Wong, J., Zhou, Q. T., Leung, S. S. Y., & Chan, H. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0114-y · Cited by 88
Arndt, C. A. S., Koshkina, N., Inwards, C. Y., Hawkins, D. S., Krailo, M., Villaluna, D., Anderson, P. M., Goorin, A. M., Blakely, M. L., Bernstein, M. L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0662 · Cited by 83
Multifunctional Pharmaceutical Nanocarriers
Torchilin, V. P. (2008) · Fundamental biomedical technologies · doi:10.1007/978-0-387-76554-9 · Cited by 82
Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids.
Shah, V., Taratula, O., Garbuzenko, O. B., Patil, M. L., Savla, R., Zhang, M., & Minko, T. (2013) · PubMed · Cited by 81
Self-citationCombination Chemotherapeutic Dry Powder Aerosols via Controlled Nanoparticle Agglomeration
El-Gendy, N. A., & Berkland, C. J. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9886-2 · Cited by 78
Aerosolized Gemcitabine in Patients with Carcinoma of the Lung: Feasibility and Safety Study
Lemarié, É., Vecellio, L., Hureaux, J., Prunier, C., Valat, C., Grimbert, D., Boisdron‐Celle, M., Giraudeau, B., Pape, A. L., Pichon, É., et al. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0872 · Cited by 77
Cagle, P. T., Zhai, Q. “., Murphy, L., & Low, P. S. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0176-oa · Cited by 77
Pulmonary monoclonal antibody delivery via a portable microfluidic nebulization platform
Cortez‐Jugo, C., Qi, A., Rajapaksa, A. E., Friend, J. R., & Yeo, L. Y. (2015) · Biomicrofluidics · doi:10.1063/1.4917181 · Cited by 76
WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth
Zamora-Ávila, D. E., Zapata‐Benavides, P., Franco-Molina, M. Á., Saavedra-Alonso, S., Trejo-Avila, L. M., Reséndez‐Pérez, D., Méndez-Vázquez, J. L., Isaias-Badillo, J., & Rodrı́guez-Padilla, C. (2009) · Cancer Gene Therapy · doi:10.1038/cgt.2009.35 · Cited by 75
Alton, E. W. F. W., Boyd, A. C., Cheng, S. H., Cunningham, S., Davies, J. C., Gill, D. R., Uta Griesenbach, D., Higgins, T., Hyde, S. C., Innes, J. A., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203309 · Cited by 75
Gaspar, M. M., Radomska, A., Gobbo, O. L., Bakowsky, U., Radomski, M. W., & Ehrhardt, C. (2012) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0928 · Cited by 73
The Airways, a Novel Route for Delivering Monoclonal Antibodies to Treat Lung Tumors
Maillet, A., Guilleminault, L., Lemarié, É., Lerondel, S., Azzopardi, N., Montharu, J., Congy‐Jolivet, N., Reverdiau, P., Legrain, B., Parent, C., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0442-5 · Cited by 72
Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery
Kalantarian, P. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12415 · Cited by 70
Targeted Proapoptotic Anticancer Drug Delivery System
Chandna, P., Saad, M., Wang, Y., Ber, E., Khandare, J. J., Vetcher, A. A., Soldatenkov, V. A., & Minko, T. (2007) · Molecular Pharmaceutics · doi:10.1021/mp070053o · Cited by 69
Self-citationMeenach, S. A., Anderson, K. W., Hilt, J. Z., McGarry, R. C., & Mansour, H. M. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0182-z · Cited by 69
Chou, A. J., Gupta, R., Bell, M. D., O’Day, K., Meyers, P. A., & Gorlick, R. G. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24438 · Cited by 68
Labile Catalytic Packaging of DNA/siRNA: Control of Gold Nanoparticles “out” of DNA/siRNA Complexes
Chen, A. M., Taratula, O., Wei, D., Yen, H.-I., Thomas, T., Thomas, T., Minko, T., & He, H. (2010) · ACS Nano · doi:10.1021/nn901796n · Cited by 66
Self-citationSelected Contribution: Lung hypoxia: antioxidant and antiapoptotic effects of liposomal α-tocopherol
Minko, T., Stefanov, A., & Pozharov, V. P. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00007.2002 · Cited by 64
Self-citationMinko, T., Kopečková, P., Pozharov, V., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007500412442 · Cited by 62
Self-citationYang, W. P., Chow, K. T., Lang, B., Wiederhold, N. P., Johnston, K. P., & Williams, R. O. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.01.001 · Cited by 57
Wang, Y., Saad, M., Pakunlu, R. I., Khandare, J. J., Garbuzenko, O. B., Vetcher, A. A., Soldatenkov, V. A., Pozharov, V. P., & Minko, T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2020 · Cited by 57
Self-citationZarogouldis, P., Karamanos, N. K., Porpodis, Κ., Domvri, K., Huang, H., Hohenforst-Schimdt, W., Goldberg, E. P., & Zarogoulidis, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130910828 · Cited by 54
Magnetised Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery
Upadhyay, D., Scalia, S., Vogel, R., Wheate, N., Salama, R., Young, P. M., Traini, D., & Chrzanowski, W. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0774-9 · Cited by 52
Zhang, M., Garbuzenko, O. B., Reuhl, K. R., Rodríguez-Rodríguez, L., & Minko, T. (2012) · Nanomedicine · doi:10.2217/nnm.11.131 · Cited by 52
Self-citationAerosolized Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Therapy in Metastatic Cancer
Rao, R. D., Anderson, P. M., Arndt, C. A. S., et al. (2003) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000037664.04141.d0 · Cited by 51
Nanotechnology approaches for inhalation treatment of fibrosis
Savla, R., & Minko, T. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.829078 · Cited by 50
Self-citationTumor-Targeted Responsive Nanoparticle-Based Systems for Magnetic Resonance Imaging and Therapy
Savla, R., Garbuzenko, O. B., Chen, S., Rodríguez-Rodríguez, L., & Minko, T. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1436-x · Cited by 49
Self-citationJiang, H., Hong, S., Kim, Y.-K., Islam, M. A., Kim, H.-J., Choi, Y., Nah, J., Lee, K.-H., Han, K., Chae, C., et al. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.045 · Cited by 48
Formulations for Pulmonary Administration of Anticancer Agents to Treat Lung Malignancies
Carvalho, T. C., Carvalho, S. R., & McConville, J. T. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0794 · Cited by 47
LHRH-Targeted Nanoparticles for Cancer Therapeutics
Minko, T., Patil, M. L., Zhang, M., Khandare, J. J., Saad, M., Chandna, P., & Taratula, O. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-609-2_19 · Cited by 45
Self-citationInhaled Voriconazole for Prevention of Invasive Pulmonary Aspergillosis
Tolman, J. A., Wiederhold, N. P., McConville, J. T., Najvar, L. K., Bocanegra, R. A., Peters, J. I., Coalson, J. J., Graybill, J. R., Patterson, T. F., & Williams, R. O. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01657-08 · Cited by 45
Huland, E., Burger, A., Fleischer, J., Fornara, P., Hatzmann, E., Heidenreich, A., Heinzer, H., Heynemann, H., Hoffmann, L., Hofmann, R., et al. (2003) · Folia Biologica · doi:10.14712/fb2003049050183 · Cited by 42
Tang, B. C., Fu, J., Watkins, D. N., & Hanes, J. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.033 · Cited by 41
Guma, S. R., Lee, D. A., Yu, L., Gordon, N. B., & Kleinerman, E. S. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.25019 · Cited by 40
Shen, J., Chelvam, V., Cresswell, G. M., & Low, P. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp3006962 · Cited by 40
Yang, Y., Cheow, W. S., & Hadinoto, K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.036 · Cited by 39
Lehofer, B., Bloder, F., Jain, P., Marsh, L. M., Leitinger, G., Olschewski, H., Leber, R., Olschewski, A., & Prassl, R. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.10.009 · Cited by 38
Surfactants: Their Critical Role in Enhancing Drug Delivery to the Lungs
Morales, J. O., Peters, J. I., & Williams, R. O. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.15 · Cited by 38
Wang, Y., & Minko, T. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.017 · Cited by 37
Self-citationLiposomes in Diagnosis and Treatment of Cardiovascular Disorders
Levchenko, T. S., Hartner, W. C., & Torchilin, V. P. (2012) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-8-1-36 · Cited by 36
Targeting pulmonary metastases of renal cell carcinoma by inhalation of interleukin-2
Merimsky, O., Gez, E., Weitzen, R., Nehushtan, H., Rubinov, R., Hayat, H. M. S., Peretz, T., Ben-Shahar, M., Biran, H., Katsenelson, R., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh137 · Cited by 35
Reed, M. D., Tellez, C. S., Grimes, M. J., Picchi, M. A., Tessema, M., Cheng, Y. S., March, T. H., Kuehl, P. J., & Belinsky, S. A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.575 · Cited by 34
Peddada, L. Y., Garbuzenko, O. B., Devore, D. I., Minko, T., & Roth, C. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.023 · Cited by 33
Self-citationPosch, C., Weihsengruber, F., Bartsch, K., Feichtenschlager, V., Sanlorenzo, M., Vujic, I., Itzinger-Monshi, B., Ortiz‐Urda, S., & Rappersberger, K. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.62 · Cited by 30
A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma
Markovic, S. N., Suman, V. J., Nevala, W. K., Geeraerts, L., Creagan, E. T., Erickson, L. A., Rowland, K. M., Morton, R. F., Horvath, W. L., & Pittelkow, M. R. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318173a536 · Cited by 28
Immunogenicity of coiled-coil based drug-free macromolecular therapeutics
Kverka, M., Hartley, J. M., Chu, T.-W., Yang, J., Heidchen, R., & Kopeček, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.063 · Cited by 25
Proapoptotic lipid nanovesicles: Synergism with paclitaxel in human lung adenocarcinoma A549 cells
Joshi, N., Shanmugam, T., Kaviratna, A., & Banerjee, R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.025 · Cited by 24
Kim, Y.-K., Cho, C., Cho, M., & Jiang, H. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34905 · Cited by 24
McCormack, P. L., & Lyseng-Williamson, K. A. (2007) · Drugs · doi:10.2165/00003495-200767160-00007 · Cited by 23
Mérian, J., Souza, R. D., Dou, Y. N., Ekdawi, S. N., Ravenelle, F., & Allen, C. J. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.060 · Cited by 22
Effect of fractalkine-Fc delivery in experimental lung metastasis using DNA/704 nanospheres
Richard, P., Cambien, B., Pradelli, E., Beilvert, F., Pitard, B., Schmid‐Antomarchi, H., & Schmid‐Alliana, A. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.42 · Cited by 21
Betigeri, S., Zhang, M., Garbuzenko, O. B., & Minko, T. (2010) · Drug Delivery and Translational Research · doi:10.1007/s13346-010-0003-1 · Cited by 19
Self-citationEsteban, E., Carballido, J., Navas, V., Torregrosa, Z., Muñoz, A., & Álvarez‐Mon, M. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328011a4fc · Cited by 18
Defense Mechanisms of the Respiratory System and Aerosol Production Systems
Zarogoulidis, P., Darwiche, K., Yarmus, L. B., Spyratos, D., Sečen, N., Hohenforst‐Schmidt, W., Katsikogiannis, N., Huang, H., Gschwendtner, A., & Zarogoulidis, P. (2014) · Medicinal Chemistry · doi:10.2174/157340641130900041 · Cited by 17
Preclinical evaluation of tacrolimus colloidal dispersion for inhalation
Watts, A. B., Peters, J. I., Talbert, R. L., O’Donnell, K. P., Coalson, J. J., & Williams, R. O. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.11.013 · Cited by 16
Berger, W. E., & Noonan, M. J. (2010) · Journal of Asthma · doi:10.3109/02770901003725684 · Cited by 13
Glucosylated polyethylenimine as a tumor-targeting gene carrier
Park, I. K., Cook, S. E., Kim, Y. K., Kim, H., Cho, M., Jeong, H. J., Kim, E. M., Nah, J. W., Born, H. S., & Cho, C. S. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02978216 · Cited by 13
Minai‐Tehrani, A., Park, Y.-C., Hwang, S.-K., Kwon, J., Chang, S.-H., Park, S. J., Yu, K.-N., Kim, J., Shin, J.-Y., Kim, J., et al. (2011) · Journal of Veterinary Science · doi:10.4142/jvs.2011.12.4.309 · Cited by 9
Cited by
Xu, M., Qi, Y., Liu, G., Song, Y., Jiang, X., & Du, B. (2023) · ACS Nano · doi:10.1021/acsnano.3c05853 · Cited by 632
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Majumder, J., & Minko, T. (2021) · The AAPS Journal · doi:10.1208/s12248-020-00532-2 · Cited by 505
Self-citationNanoparticles in Drug Delivery: From History to Therapeutic Applications
Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468
Current applications of nanoparticles in infectious diseases
Zazo, H., Colino, C. I., & Lanao, J. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.008 · Cited by 434
Abdelaziz, H. M., Gaber, M., Abd-Elwakil, M. M., Mabrouk, M. T., Elgohary, M. M., Kamel, N. M., Kabary, D. M., Freag, M. S., Samaha, M. W., Mortada, S. M., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.036 · Cited by 409
Metadata
- Authors
- Kuzmov, A., & Minko, T.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 219
- Pages
- 500-518
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W1135720400
- Cited by
- 352
- References
- 125
- FWCI
- 18.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.